메뉴 건너뛰기
Hematology and Cell Therapy
Volumn 38, Issue 5, 1996, Pages 459-460
Graft-versus-host disease and graft-versus-leukemia
Author keywords

[No Author keywords available]
Indexed keywords

CONFERENCE PAPER; GRAFT VERSUS HOST REACTION; GRAFT VERSUS LEUKEMIA EFFECT; HUMAN; STEM CELL TRANSPLANTATION;
EID: 0029807768     PISSN: 14302772     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00282-996-0459-0     Document Type: Conference Paper
Times cited : (6)
References (15)
  • 2
    • 0027437385 scopus 로고
    • Savage immunotherapy using donor leukocyte infusions as treatment for relapsed chronic myelogenous leukemia after allogeneic bone marrow transplantation : Efficacy and toxicity of a defined T cell dose
    • Drobyski WR, Keever CA, Roth MS, Koethe S, Hanson G, McFadden P, Gottschall JL, Ash RC, van Tuinen P, Horowitz MM, Flomenberg N (1993) Savage immunotherapy using donor leukocyte infusions as treatment for relapsed chronic myelogenous leukemia after allogeneic bone marrow transplantation : efficacy and toxicity of a defined T cell dose. Blood 82 : 2310
    • (1993) Blood , vol.82 , pp. 2310
    • Drobyski, W.R.1    Keever, C.A.2    Roth, M.S.3    Koethe, S.4    Hanson, G.5    McFadden, P.6    Gottschall, J.L.7    Ash, R.C.8    Van Tuinen, P.9    Horowitz, M.M.10    Flomenberg, N.11
  • 3
    • 1842403447 scopus 로고
    • CD8+depleted donor lymphocyte infusion as treatment for relapsed chronic myelogenous leukemia after allogeneic bone marrow transplantation : Graft vs leukemia without graft vs host disease
    • Giralt S, Hester J, Huh Y, Hirsch-Ginsberg C, Rondon G, Guo J, Lee M, Gajewski J, Talpaz M, Kantarjian H, Fischer H, Deisseroth A, Champlin R (1994) CD8+depleted donor lymphocyte infusion as treatment for relapsed chronic myelogenous leukemia after allogeneic bone marrow transplantation : graft vs leukemia without graft vs host disease (abstract). Blood 84 [Suppl 1] : 538
    • (1994) Blood , vol.84 , Issue.1 SUPPL. , pp. 538
    • Giralt, S.1    Hester, J.2    Huh, Y.3    Hirsch-Ginsberg, C.4    Rondon, G.5    Guo, J.6    Lee, M.7    Gajewski, J.8    Talpaz, M.9    Kantarjian, H.10    Fischer, H.11    Deisseroth, A.12    Champlin, R.13
  • 5
    • 0027331359 scopus 로고
    • Interfero-alpha and donor buffy coat transfusions for treatment of relapsed chronic myeloid leukemia after allogeneic bone marrow transplantation
    • Hertenstein B, Wiesneth M, Novotny J, Bunjes D, Stefanic M, Heinze B, Hubner G, Heimpel H, Arnold R (1993) Interfero-alpha and donor buffy coat transfusions for treatment of relapsed chronic myeloid leukemia after allogeneic bone marrow transplantation. Transplantation 56 : 1114
    • (1993) Transplantation , vol.56 , pp. 1114
    • Hertenstein, B.1    Wiesneth, M.2    Novotny, J.3    Bunjes, D.4    Stefanic, M.5    Heinze, B.6    Hubner, G.7    Heimpel, H.8    Arnold, R.9
  • 7
    • 0027537527 scopus 로고
    • Delayed infusion of nomal donor cells after MHC-matched bone marrow transplantation provides an antileukemia reaction without graft-versus-host disease
    • Johnson BD, Drobyski WR, Truitt RL (1993) Delayed infusion of nomal donor cells after MHC-matched bone marrow transplantation provides an antileukemia reaction without graft-versus-host disease. Bone Marrow Transplant 11 : 329
    • (1993) Bone Marrow Transplant , vol.11 , pp. 329
    • Johnson, B.D.1    Drobyski, W.R.2    Truitt, R.L.3
  • 8
    • 0025678601 scopus 로고
    • Donor leukocyte transfusions for treatment of recurrent chronic myelogenous leukemia in marrow transplant patients
    • Kolb HJ, Mittermuller J, Clemm CH, Holler B, Ledderose G, Brehm G, Heim M, Wilmanns W (1990) Donor leukocyte transfusions for treatment of recurrent chronic myelogenous leukemia in marrow transplant patients. Blood 76 : 2462
    • (1990) Blood , vol.76 , pp. 2462
    • Kolb, H.J.1    Mittermuller, J.2    Clemm, C.H.3    Holler, B.4    Ledderose, G.5    Brehm, G.6    Heim, M.7    Wilmanns, W.8
  • 10
    • 0028206129 scopus 로고
    • Minimal residual disease is more common in patients who have mixed T cell chimerism after bone marrow transplantation for chronic myelogenous leukemia
    • Mackinnon S, Barnett L, Heller G, O'Reilly RJ (1994) Minimal residual disease is more common in patients who have mixed T cell chimerism after bone marrow transplantation for chronic myelogenous leukemia. Blood 83 : 3409
    • (1994) Blood , vol.83 , pp. 3409
    • Mackinnon, S.1    Barnett, L.2    Heller, G.3    O'Reilly, R.J.4
  • 12
    • 23444449333 scopus 로고
    • Induction of graft-versus-host disease as immunotherapy for relapsed chronic myeloid leukemia
    • Porter DL, Roth MS, McCarigle C, Ferrara JLM, Antin JH (1994) Induction of graft-versus-host disease as immunotherapy for relapsed chronic myeloid leukemia. N Engl J Med 330 : 100
    • (1994) N Engl J Med , vol.330 , pp. 100
    • Porter, D.L.1    Roth, M.S.2    McCarigle, C.3    Ferrara, J.L.M.4    Antin, J.H.5
  • 13
    • 0028237517 scopus 로고
    • Relapse of chronic myeloid leukemia after allogeneic bone marrow transplant : The case for giving donor leukocyte transfusions before the onset of hematologic relapse
    • van Rhee F, Lin F, Cullis JO, Spencer A, Cross NCP, Chase A, Garicocfaea B, Bungey J, Barrett J, Goldman JM (1994) Relapse of chronic myeloid leukemia after allogeneic bone marrow transplant : The case for giving donor leukocyte transfusions before the onset of hematologic relapse. Blood 83 : 3377
    • (1994) Blood , vol.83 , pp. 3377
    • Van Rhee, F.1    Lin, F.2    Cullis, J.O.3    Spencer, A.4    Cross, N.C.P.5    Chase, A.6    Garicocfaea, B.7    Bungey, J.8    Barrett, J.9    Goldman, J.M.10

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.